Patent Application
20130053800
1. Field of the Invention
The present invention pertains to wound management. More particularly, the present invention pertains to a wound management system that employs reduced pressure to remove wound exudate and a dressing that will contain and isolate the wound where the dressing must remain on the wound for a prolonged period of time.
2. Description of Related Art
The recent protracted combat operations of the U.S. Armed Forces in both Afghanistan and Iraq have been remarkable in the comparatively low level of fatalities compared to other conflict involving U.S. Armed Forces, such as the combat operations in Viet Nam. The reason for the comparatively low level of fatalities is because of the dramatic improvements that have been made in protective body armor and medical care. Significant improvements have been made to procedures and techniques for stabilizing and removing injured personnel from the battlefield to a facility where medical care may be administered by personnel with proper equipment. While there has been a dramatic decrease in the loss of life, there also has been a corresponding increase in the number of service members wounded. As in many combat situations, a frequent injury to those in ground combat operations is a deep, traumatic wound. Many military trauma wounds are inherently contaminated and can become severely infected because of prolonged contact with the ground on the battlefield or lengthy periods without treatment. Field medics are taught how to irrigate and/or clean deep wounds and then cover the wound with some type of wound dressing. The wound dressing performs several functions. A dressing often includes a powder, an ointment, or a salve, which may kill some of the toxic bacteria that have entered the wound. Second, the dressing covers the wound to help prevent entry of additional toxic bacteria. Third, the dressing decreases the chance of cross-contaminating other wounds on a patient's body. Fourth, the dressing absorbs fluids or exudate from the wound.
When wounds are large or deep, however, several treatment problems arise. Because medical evacuation routes can extend thousands of miles, it is not uncommon for wounded soldiers to experience several days in the medical evacuation process. While wounded personnel are in transport, it is generally not possible to provide the type of wound treatment care available in a hospital. A gauze dressing may not have sufficient fluid retention capacity to adequately absorb all of the exudate from some wounds, and so may become saturated with exudate. Saturated dressings may not be easily exchanged for non-saturated dressings during medical evacuation and transport by aircraft or ground/water transport vehicles. A typical mounting arrangement in medical transport/evacuation vehicles involves stacking patient gurneys three or four high, often against a wall or bulkhead. Such stacking of gurneys may limit access to exudating wounds of those patients on the gurneys such that medical personnel often cannot readily tend to dressings or any other equipment used to protect wounds.
During all parts of the medical evacuation process, there is a need to provide wound exudate management and wound isolation with the wound contained in a closed protective environment. Further, there is a need to remove and isolate wound exudate so that the wound exudate, a biohazardous material, can be collected and properly discarded. Such removal and isolation of wound exudate will reduce cross-contamination, reduce the risk of infection, and facilitate effective wound management during the transport of injured soldiers. There is a need to provide a system that is compact so that it may be easily carried and is not dependent on any external source of energy for operation. Finally, there is a need to provide a system that will be U.S. Military Flight Certified, a non-capital level asset, and disposable.
The problems presented by existing wound isolation systems and methods are solved by the systems and methods of the present invention. A wound exudate removal and isolation system in accordance with one embodiment of the present invention includes a porous dressing, a canister in fluid communication with the porous dressing, and a first valve positioned between the porous dressing and the canister. The first valve is positionable in an open position to allow fluid flow and a closed position to prevent fluid flow between the porous dressing and the canister. A disposal line is fluidly connected to the canister, and a second valve is operably positioned within the disposal line. The second valve is positionable in an open position to allow fluid flow and a closed position to prevent fluid flow through the disposal line. A pump is positioned in fluid communication with the canister and is operable to draw wound exudate from the porous dressing into the canister when the first valve is open and the second valve is closed. The pump further is operable to force wound exudate from the canister into the disposal line when the first valve is closed and the second valve is open.
In accordance with another embodiment of the present invention, a wound treatment apparatus includes a means for dressing a wound, a means for drawing exudate from the wound into a canister, a means for isolating the wound, and a means for forcing exudate from the canister.
In accordance with another embodiment of the present invention, a wound stasis and isolation apparatus includes an open-cell, reticulated foam dressing having an average pore size less than about 200 microns. A drape is provided to cover the foam dressing and the wound. A pump is positioned in fluid communication with the foam dressing to draw wound exudate from the wound at a pressure less than about 125 mmHg to maintain wound drainage and moisture control at the wound but minimize tissue in-growth into the foam dressing.
In accordance with another embodiment of the present invention, a method of providing stasis and isolation to a wound is provided. The method includes positioning an open-cell, reticulated foam dressing adjacent the wound, the foam dressing having an average pore size less than about 200 microns. A drape is positioned over the foam dressing and the wound, and a reduced pressure of less than about 100 mmHg is applied to the foam dressing.
Other objects, features, and advantages of the present invention will become apparent with reference to the drawings and detailed description that follow.
In the following detailed description of the preferred embodiments, reference is made to the accompanying drawings that form a part hereof, and in which is shown by way of illustration specific preferred embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the invention, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined only by the appended claims.
The wound exudate removal and isolation system 100 provides a dressing and a cover 110 over the wound, which draws exudate from the wound and moves the exudate to an exudate collection system 120 through the application of a vacuum, or reduced pressure. With traditional reduced pressure delivery systems, the distribution of reduced pressure at the wound site is used to encourage new tissue growth. The wound exudate removal and isolation system 100 is preferably used to isolate, protect, and provide stasis to the wound site until the patient arrives at a medical facility where the wound may be properly treated. The system 100 is therefore configured to provide adequate wound drainage and moisture control capabilities, while minimizing the in-growth of new tissue into the dressing.
When a foam dressing is used, the dressing 1.0 dressing includes pores of a size that allow wound exudate to pass from a wound into tubing 1.2, but minimize the in-growth of tissue into the pores. The average pore size is typically between about 40 and 200 μm, and preferably about 100 μm. The pore sizes associated with dressing 1.0 are typically smaller than the pore sizes associated with dressings used to promote wound healing. The porous dressing 1.0 may also have anti-microbial properties. In one embodiment, the dressing may be coated or impregnated with an antimicrobial agent such as silver.
A drape 1.1 is placed over the foam dressing 1.0 to isolate the wound and allow for the application of a reduced pressure to the wound 1.0 through tubing 1.2. In one embodiment, tubing 1.2 is a plastic tubing. The dressing 1.0, the drape 1.1, and a tubing 1.2 may be contained in a small, lightweight kit, which can be easily deployed with and stocked by Forward Military Medical Units.
The reduced pressure applied to the dressing 1.0 is strong enough to continuously draw exudate from the wound through the tubing 1.2. Unlike reduced pressure systems that are used to promote the growth of granulation tissue at the wound, the primary purpose of system 100 is to isolate and contain wounds and remove exudate. While the reduced pressure applied to the wound through the dressing 1.0 may be adjusted depending on the size of the wound and the porosity of the dressing 1.0, it is preferred that the pressure applied to the wound be less than about 125 mmHg. This particular pressure is typically considered the minimum pressure at which new tissue growth is accelerated in wounds; hence, it is desired to remain below this pressure to minimize new tissue growth. More preferably, the pressure applied to the wound through the dressing will be between about 25 and 75 mmHg.
Again referring to
Since the system 100 may be placed at the wound for extended periods of time during patient transport, it may be desired to drain the canister 8 while leaving the remainder of the system 100 in place. Valves 3, 4 are provided to allow drainage of the canister 8 when full or when desired by the person attending to the wound. During the application of reduced pressure to the wound, valve 3 is open to provide fluid communication between the dressing 1.0 and the canister 8. In this configuration, valve 4 is closed to prevent drainage of the canister 8. To drain the canister 8, valve 3 is closed and valve 4 is opened. The closing of valve 3 prevents reduced pressure from being applied to the wound, while the opening of valve 4 allows wound exudate in the canister 8 to drain through the disposal line 14. Optionally, a disposable container 7 may be connected to the disposal line 14 to collect the wound exudate drained from the canister 8. The disposable container 7 may be a flexible, vented disposal bag. When the disposable container 7 is full, it may be removed and replaced with an empty container.
Reduced pressure is provided to the dressing 1.0 through the canister by a pump 11 that is fluidly connected to the canister. In one embodiment pump 11 is a battery-operated vacuum/pressure pump. Alternatively, the pump 11 may be manually operated, or may be any other pump suitable for inducing the pressures disclosed herein. As the pump 11 applies a reduced pressure to the dressing 1.0 through the canister 8, wound exudate is drawn from the wound and deposited in canister 8. This operation occurs when the valve 3 is in an open position and the valve 4 is in a closed position.
As previously described, the canister 8 may be drained by positioning valve 3 in a closed position and valve 4 in an open position. While the drainage operation may be facilitated by gravitational force, the wound exudate may alternatively be forced out of the canister 8 into the disposal line 14 by the pump 11. To facilitate forced drainage of the canister 8, a three-way valve 9 is fluidly connected between the canister 8 and an inlet of the pump 11. The valve 9 is selectively positionable between an active position and a vent position. In the active position, the valve 9 allows fluid communication between the canister and the inlet of the pump 11. In the vent position, the inlet of the pump 11 is vented. Another three-way valve 10 is fluidly connected between the canister 8 and an outlet of the pump 11. The valve 10 is selectively positionable between an active position and a vent position. In the active position, the valve 10 allows fluid communication between the canister and the outlet of the pump 11. In the vent position, the outlet of the pump 11 is vented. The positioning of the valves 9, 10 is linked such that a positioning of the valve 9 in the active position results in a positioning of the valve 10 in the vent position. Similarly, a positioning of the valve 9 in the vent position results in a positioning of the valve 10 in the active position.
When valve 9 is positioned in the active position and valve 10 is positioned in the vent position, the pump 11 is configured to draw wound exudate from the dressing 1.0 into the canister 8. In this reduced pressure configuration, valve 3 is positioned in the open position and valve 4 is positioned in the closed position. When valve 9 is positioned in the vent position and valve 10 is positioned in the active position, the pump 11 is configured to provide a positive pressure to the canister to force wound exudate from the canister 8 into the disposal line 14. In this positive pressure configuration, valve 3 is positioned in the closed position and valve 4 is positioned in the open position.
A hydrophobic filter 8.1 also may be included in fluid communication with the canister 8 to prevent fluid from entering the tubing attached to pump 11 and valves 9 and 10.
In one embodiment, a sensor may be operably associated with the canister 8 to detect when the canister 8 is full of wound exudate. The sensor may be operably connected to the valves 3, 4, 9, 10 to automatically adjust the operation of the system 100 from a reduced pressure system to a positive pressure system so that exudate is moved from the canister 8 to the disposable container 7 when the canister 8 is full.
The system may further include a safety alarm system that provides either an audio signal or a visual signal if the system is not operating properly. The safety alarm system is configured to avoid producing false alarms in response to typical patient conditions that may occur during the medical evacuation process. However, some events that may be detected by the safety alarm system include, but are not limited to, leak detection events, blockage events, full canister events, low pressure events, high pressure events, and low battery events.
The system may also include blood detection sensors to prevent exsanguination or the removal of copious or unhealthy amounts of blood from a patient.
As shown in
It should be apparent from the foregoing that an invention having significant advantages has been provided. While the invention is shown in only a few of its forms, it is not just limited but is susceptible to various changes and modifications without departing from the spirit thereof.
This application is a continuation of U.S. patent application Ser. No. 11/634,719, entitled “Wound Exudate Removal and Isolation System,” filed Dec. 6, 2006, which application claims the benefit of U.S. Provisional Application No. 60/742,755, entitled “Wound Exudate Removal and Isolation System,” filed Dec. 6, 2005, and these applications are incorporated herein by reference for all purposes.
| Number | Date | Country | |
|---|---|---|---|
| 60742755 | Dec 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11634719 | Dec 2006 | US |
| Child | 13591324 | US |
